Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,0811,100 of 20,252 grants

Active NON-SBIR/STTR RPGS
Development of Novel Heterogeneous Range Modulators for FLASH Particle Therapy
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2026

FLASH radiotherapy utilizing ultra-high dose rate has the potential of being a substantial evolutionary advancement for cancer treatment. Ultra-high dose rate radiation provides a...

$4.03M
USD
Active NON-SBIR/STTR RPGS
The role of HPF1 in radiation and genotoxic cancer therapy
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Cancer radiation therapy generates reactive oxygen species (ROS), which cause both single and double-strand DNA breaks that rapidly recruit and activate Po...

$6.13M
USD
Active NON-SBIR/STTR RPGS
Addressing racial disparities in colorectal cancer risk prediction
NATIONAL CANCER INSTITUTE Boston University Medical Campus United States 2024 – 2028

PROJECT SUMMARY With Black men and women experiencing a disproportionately high burden of colorectal cancer (CRC), there is a critical need for new improved risk prediction tools t...

$7.17M
USD
Active SBIR-STTR RPGS
Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development
NATIONAL CANCER INSTITUTE Xylyx Bio, Inc United States 2024 – 2027

PROJECT ABSTRACT Xylyx is developing a predictive multi-organ metastatic breast cancer cell-based assay platform to address the lack of in-vitro models of organotropic metastatic b...

$2.96M
USD
Active NON-SBIR/STTR RPGS
Quantifying patient-provider communication using machine learning to assess its impact on metastatic cancer patients' outcomes
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2029

About two million persons are diagnosed with cancer every year in the US. The Effective clinical management of cancer patients including the use of oral therapies can improve outco...

$7.1M
USD
Active NON-SBIR/STTR RPGS
Targeting DYRK2 to eradicate leukemia stem cells in chronic myeloid leukemia.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2024 – 2029

Project Summary Chronic myeloid leukemia (CML) is an aggressive hematological malignancy caused by the oncoprotein BCRABL1. Although tyrosine kinase inhibitors (TKIs) can help CML...

$4.26M
USD
Active NON-SBIR/STTR RPGS
Mechanism by which ketogenic diet uncouples tumor growth and overall survival
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2024 – 2029

The overarching goal of this proposal is to add to the understanding of the complex interaction between the tumor and the host organism to facilitate new therapeutic approaches in...

$5.3M
USD
Completed SBIR-STTR RPGS
Antibody-based prertargeted alpha particle therapy for ovarian cancer
NATIONAL CANCER INSTITUTE Viewpoint Molecular Targeting, Inc United States 2024 – 2025

Project Summary High-grade serous ovarian carcinomas (HGSOC) account for 75% of ovarian cancer diagnoses, and about 80% of patients have metastatic disease upon diagnosis. Metastat...

$3.92M
USD
Active NON-SBIR/STTR RPGS
Stromal Effects in Head and Neck Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2029

Squamous cell carcinoma of the head and neck (HNSCC) is a complex disorder that contains multiple cell populations, making it is difficult to study the nature and cellular function...

$3.72M
USD
Active NON-SBIR/STTR RPGS
Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in Lymph
NATIONAL CANCER INSTITUTE Harvard School of Public Health United States 2024 – 2029

ABSTRACT Although most melanoma deaths are caused by distant metastasis, the mechanisms that regulate metastasis are poorly understood. During metastasis, cancer cells encounter ox...

$4.23M
USD
Active NON-SBIR/STTR RPGS
Targeting retrotransposons for improved treatment of refractory childhood cancer
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2024 – 2029

Despite notable improvements in childhood cancer survival rates, patients with relapsed or refractory disease face grim prospects, and childhood cancer remains the commonest cause...

$6.02M
USD
Active NON-SBIR/STTR RPGS
Deciphering the Mechanism of Lymphovascular Space Invasion Using a Lymphovascularized Bioengineering Breast Stromal Platform
NATIONAL CANCER INSTITUTE University of Texas At Austin United States 2024 – 2029

Highly aggressive cancers are frequently characterized by tumor cell emboli within the lymphatic and blood vasculature. Termed lymphovascular space invasion (LVSI), this phenomenon...

$6.69M
USD
Active NON-SBIR/STTR RPGS
A novel engineered IL-21-based immunocytokine as a therapeutic approach for tumor targeting in renal cancer
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Renal cell cancer (RCC) is a lethal disease whose incidence is on the rise. Clear cell renal cell cancer (ccRCC), the most aggressive and the deadliest var...

$4.83M
USD
Active NON-SBIR/STTR RPGS
Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2029

Project Summary An adaptive immunosuppressive microenvironment is a major barrier to immune-based therapies for solid tumors, including glioblastoma (GBM). Current model systems fo...

$6.2M
USD
Active TRAINING, INDIVIDUAL
Investigation of Immunotherapy-induced Alterations to Cellular Communication Networks in Pancreatic Ductal Adenocarcinoma
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2026

PROJECT SUMMARYPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest forms of cancer in the United States. The low mutationalburden in PDAC leads to low infiltration of T...

$489.7K
USD
Completed RESEARCH CENTERS
MOSAIC: Administrative Core
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2024 – 2025

SUMMARY: ADMINISTRATIVE CORE The overarching objective for the Mayo/Columbia MOSAIC CSBC is to build a conceptual framework to understand tissue state transitions that happen in gl...

Completed OTHERS
The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer Cachexia
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2025

Abstract Background Cancer cachexia (CC) is a systemic, metabolic wasting syndrome featuring body weight loss due to skeletal muscle and adipose tissue wasting. CC is suffered by ~...

$5.71M
USD
Completed RESEARCH CENTERS
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT This is a Supplement requesting interim funds to support the Vanderbilt-Ingram Cancer Center GI SPORE, which continues to focus on colorectal cancer, the s...

$8.96M
USD
Completed RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT: Administrative Core The Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal (GI) Cancer Administrative Core will support all GI SPORE cancer-related...

Completed RESEARCH CENTERS
Core 1: Tissue Pathology and Cellular Analysis
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2024 – 2025

Project Summary/Abstract: Tissue Pathology and Cellular Analysis Core The Translational Pathology and Cellular Analysis (TPCA) Core, will play a central role in the translational r...